This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To determine the benefits and harms of bisphosphonates, parathyroid or parathyroid-related protein analogues, denosumab, and romosozumab therapy for the primary and secondary prevention of fractures in men.